Evidence map›Paper›PMID 28808580›Full record

ArticleJournal of pharmaceutical health care and sciences2017

The detection of influenza virus at the community pharmacy to improve the management of local residents with influenza or influenza-like disease.

Akio Kawachi, Yusuke Sakamoto, Shunya Mouri, Mitsuaki Fukumori, Riku Kawano, Takaya Murakami, Junichiro Sonoda, Keiko Narumi, Yoshihiro Shimodozono, Kenji Etoh and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of pharmaceutical health care and sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Akio KawachiGraduate School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, Miyazaki, Japan.
Yusuke SakamotoGraduate School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, Miyazaki, Japan.
Shunya MouriTomitaka Pharmacy, Miyazaki, Japan.
Mitsuaki FukumoriTomitaka Pharmacy, Miyazaki, Japan.
Riku KawanoTomitaka Pharmacy, Miyazaki, Japan.
Takaya MurakamiHavas Worldwide Japan K.K, Tokyo, Japan.
Junichiro SonodaGraduate School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, Miyazaki, Japan.
Keiko NarumiGraduate School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, Miyazaki, Japan.
Yoshihiro ShimodozonoGraduate School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, Miyazaki, Japan.
Kenji EtohHyuga-city and Higashi-usuki County Pharmaceutical Association, Miyazaki, Japan.
Susumu ChiyotandaChiyoda Hospital, Miyazaki, Japan.
Takashi FuruieHyuga-city Healthcare Center, Miyazaki, Japan.
Keizo SatoGraduate School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, Miyazaki, Japan.
Masao FukumoriTomitaka Pharmacy, Miyazaki, Japan.
Toshiro MotoyaGraduate School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, Miyazaki, Japan.
Kyushu University of Health and Welfare · JPTomita Hospital · JPUniversity of Miyazaki Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAs of 2014, community pharmacies in Japan are approved by the Ministry of Health, Labour and Welfare to measure lipid panel, HbA1c, glucose, ALT, AST and γ-GTP, but not to screen for influenza virus. We provided influenza virus screening tests at a community pharmacy to triage people with symptoms suggestive of influenza. Participants were given appropriate advice on how to prevent the spread of and safeguard against influenza. We subsequently evaluated the effects of community pharmacy-based influenza virus screening and prevention measures.

methodsLocal residents with symptoms suggestive of influenza participated in this study. Influenza virus screening tests using nasal samples were provided to the pharmacy, and we assessed samples for the presence of influenza virus. The study consisted of a preliminary interview, informed consent, and screening test on Day 1, and mail-in survey on Day 14.

resultsA total 52 local residents participated in the study. The number of participants and influenza virus positive results followed the same trend as the influenza epidemic in the study area. Influenza virus was found in 28.8% of samples. There was no significant difference between the appearance ratios of subjective symptoms among influenza-positive and influenza-negative groups. The percentages of participants who were first screened at the pharmacy, and those who were first screened at a clinic and then tested again at the pharmacy, were 71.2% (37/52) and 28.8% (15/52), respectively. In the latter group, 14 of 15 were negative by screening at the clinic, and one was diagnosed with influenza without testing. Subsequently, 46.8% (7/15) of participants tested positive for influenza by pharmacy-based screening. According to the mail-in survey, all influenza-positive (100%, 7/7) and 35.3% (6/17) of influenza-negative participants visited the clinic after being tested at the community pharmacy; test results between the community pharmacy and clinic were consistent. A total 64.7% (11/17) of symptomatic participants who tested negative recovered spontaneously at home.

conclusionsImplementation of influenza virus screening followed by provision of appropriate advice for both influenza-positive and influenza-negative participants at the community pharmacy showed a significant effect on improving the health of the local community.

Indexed as

Community pharmacyInfluenzaPharmacistPoint-of-care testing

Identifiers

PMID28808580
PMCPMC5549291
OpenAlexW2743646346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.